About Us
A talent-driven, innovation-led biopharmaceutical company built on the research strength of Westlake University and Westlake Laboratory.
Bringing scientific innovation
to patients
Westlake Pharmaceuticals (Hangzhou) Co., Ltd. was founded in September 2020 and is headquartered in Hangzhou. Building on the research foundations of Westlake University and Westlake Laboratory, the company integrates cell biology, structural biology, medicinal chemistry and artificial intelligence to discover innovative drugs for major human diseases.
Our founding team is led by Dr. Hongtao Yu, a world-renowned cell biologist and Dean of the School of Life Sciences at Westlake University, together with Dr. Hu Qi and Dr. Jing Huang, Distinguished Research Fellows at the School of Life Sciences, Westlake University. Grounded in a deep understanding of the life sciences, the team builds an innovation and collaboration system dedicated to first-in-class drug discovery for major human diseases.
- Founded in Hangzhou
- 2020
- DEL compounds screened
- 49B+
- First-in-class drug approved
- 1
Our values

Begin with the end in mindReach every patient
Bold in innovationRigorous in evidence
Open and inclusiveAcross disciplines
Equal partnershipSeamless collaboration
Founding team

Dr. Hongtao Yu
Co-founder & Chairman
Co-founded Westlake Pharmaceuticals in 2020 and serves as Chairman. He is an internationally renowned cell biologist and currently serves as Dean of the School of Life Sciences at Westlake University.
Holds a bachelor’s degree in chemistry from Peking University and a Ph.D. from Harvard University, and carried out postdoctoral research at Harvard Medical School. He has served as assistant professor, associate professor and professor in the Department of Pharmacology at the University of Texas Southwestern Medical Center, and as the Serena S. Simmons Distinguished Chair, while also serving as an investigator of the Howard Hughes Medical Institute (HHMI).
Elected a Fellow of the American Association for the Advancement of Science (AAAS) in 2012, and elected to the board of the Society of Chinese Bioscientists in America in 2018.

Dr. Hu Qi
Co-founder & Director
Co-founded Westlake Pharmaceuticals in 2020 and serves as a Director. He is a Distinguished Research Fellow at Westlake University.
Holds a bachelor’s degree in pharmacy from Peking University, a master’s degree in medicinal chemistry and a Ph.D. in biology from Tsinghua University, and carried out postdoctoral research at the University of California, San Francisco, supported by a postdoctoral fellowship from the Damon Runyon Cancer Research Foundation.

Dr. Jing Huang
Co-founder & Director
Co-founded Westlake Pharmaceuticals in 2020 and serves as a Director. He is a Distinguished Research Fellow at Westlake University and a leading figure in computer-aided drug design (CADD) and AI-aided drug design (AIDD) in China.
Provides scientific advisory consulting to AI pharmaceutical companies such as XtalPi and DP Technology, as well as to leading internet companies including ByteDance, Baidu (BioMap) and Tencent, and collaborates with them on related research.
Holds a bachelor’s degree and a master’s degree in physics from Tsinghua University and a Ph.D. in chemistry from the University of Basel, Switzerland, and carried out postdoctoral research at the University of Maryland School of Pharmacy and at the NIH/NHLBI.
Our history
2020SepFounded in Yunqi Town, Hangzhou
2020DecCompleted the angel financing round
2022SepChina’s NMPA cleared our first original drug, WPV01 (iscartrelvir), to enter clinical trials
2022NovCompleted the Series A financing round
2023OctCompleted the Phase 3 clinical trial of iscartrelvir
2025SepStarted IND-enabling studies for our first oncology candidate
2026JulChina’s NMPA granted conditional approval to Mprosevir® (iscartrelvir), our first original drug
Awards and recognition

Westlake Elite Talent Programme, Class A

Hangzhou quasi-unicorn enterprise

Outstanding Enterprise, 12th China Innovation & Entrepreneurship Competition

2023 Zhejiang Top 50 Most Investable Innovative Enterprises

2024 Future Healthcare 100 · China Innovative Pharma & Biologics TOP 100

Fortune China’s 2024 list of entrepreneurial companies with the greatest social impact

Second Prize, national biomedical finals, 14th China Innovation & Entrepreneurship Competition
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
- Address
- Building 3, 2/F, No. 1 Yumeng Road, Zhuantang Subdistrict, Xihu District, Hangzhou, Zhejiang
For partnership, recruitment or media enquiries, please write to us by email or call us directly.
